Grants

FDA grants breakthrough therapy designations for canakinumab to treat periodic …
... since 2009 to treat cryopyrin-associated periodic syndrome, Muckle-Wells syndrome and familial cold autoinflammatory syndrome in patients 4 years and older. In 2013, it was approved to treat systemic juvenile idiopathic arthritis in patients 2 ... [...]
5
Like
Save
NCCN Awards Grants to Study Enzalutamide as Mantle Cell Lymphoma Treatment
The drug was approved in 2012 by the U.S. Food and Drug Administration (FDA) for the treatment of patients with metastatic castration resistant prostate cancer and is marketed in the U.S under the brand name Xtandi sold as capsules made by Medivation, ... [...]
5
Like
Save